Clinical Trial Update: Weight Adjusted Low Molecular Weight Heparin in Recurrent Implantation Failure: a Randomized Open Labeled Trial [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial of weight-adjusted low molecular weight heparin for recurrent implantation failure has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Implantation Failure
• Infertility

Drugs mentioned

• Low molecular weight heparin (low molecular weight heparin)

Snippet

Sponsor: Istituto Clinico Humanitas | Conditions: Infertility, Low Molecular Weight Heparin | Phase 3 | Status: TERMINATED